NDC 68083-381 – Irinotecan hydrochloide
Irinotecan Hydrochloride 20 mg/mL · Injection · Intravenous
Product NDC68083-381
Product details
- Brand name
- Irinotecan hydrochloide
- Generic name
- Irinotecan hydrochloide
- Labeler
- Gland Pharma Limited
- Dosage form
- Injection
- Route
- Intravenous
- Marketing category
- ANDA · ANDA212993
- Marketed since
- November 18, 2019
- Listing expires
- December 31, 2026
- Pharmacologic class
- Topoisomerase Inhibitor
Active ingredients
- Irinotecan Hydrochloride 20 mg/mL
Uses, dosage, side effects and warnings for Irinotecan hydrochloide →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 68083-381-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (68083-381-01) / 2 mL in 1 VIAL, SINGLE-DOSE | Nov 18, 2019 |